|
1
|
Christakos S, Dhawan P, Verstuyf A,
Verlinden L and Carmeliet G: Vitamin D: Metabolism, molecular
mechanism of action, and pleiotropic effects. Physiol Rev.
96:365–408. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gil Á, Plaza-Diaz J and Mesa MD: Vitamin
D: Classic and novel actions. Ann Nutr Metab. 72:87–95.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jean G, Souberbielle J and Chazot C:
Vitamin D in chronic kidney disease and dialysis patients.
Nutrients. 9(328)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sreevani M, Rao BS and Srivanvani S:
Vitamin D levels among chronic kidney disease patients at a
tertiary care hospital: A cross-sectional study. Natl J Lab Med.
13:BO01–BO04. 2024.
|
|
5
|
Franchi M, Gunnarsson J, Gonzales-Parra E,
Ferreira A, Ström O and Corrao G: Paricalcitol and extended-release
calcifediol for treatment of secondary hyperparathyroidism in
non-dialysis chronic kidney disease: Results from a network
meta-analysis. J Clin Endocrinol Metab. 108:e1424–e1432.
2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
da Silva Canhos MM, de Oliveira RC,
Modelli de Andrade LG, Caramori JCT, Barretti P and Martin LC:
Association between vitamin D levels and mortality in hemodialysis
patients: A cohort study. Ren Fail. 42:225–233. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sutherland JP, Zhou A and Hyppönen E:
Vitamin D deficiency increases mortality risk in the UK biobank: A
nonlinear mendelian randomization study. Ann Intern Med.
175:1552–1559. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Kidney Disease, Improving Global Outcomes
(KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice
guideline update for the diagnosis, evaluation, prevention, and
treatment of chronic kidney disease-mineral and bone disorder
(CKD-MBD). Kidney Int Suppl (2011). 7:1–59. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bouillon R and Bikle D: Vitamin D
metabolism revised: Fall of dogmas. J Bone Miner Res. 34:1985–1992.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pike JW and Meyer MB: The unsettled
science of nonrenal calcitriol production and its clinical
relevance. J Clin Invest. 130:4519–4521. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
van Driel M and van Leeuwen JPTM: Vitamin
D and bone: A story of endocrine and auto/paracrine action in
osteoblasts. Nutrients. 15(480)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Verlinden L and Carmeliet G: Integrated
view on the role of vitamin D actions on bone and growth plate
homeostasis. JBMR Plus. 5(e10577)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Segersten U, Correa P, Hewison M, Hellman
P, Dralle H, Carling T, Akerström G and Westin G: 25-Hydroxyvitamin
D(3)-1alpha-hydroxylase expression in normal and pathological
parathyroid glands. J Clin Endocrinol Metab. 87:2967–2972.
2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen X, Chu C, Doebis C, Xiong Y, Cao Y,
Krämer BK, von Baehr V and Hocher B: Vitamin D status and its
association with parathyroid hormone in 23,134 outpatients. J
Steroid Biochem Mol Biol. 220(106101)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Eleftheriadis T, Antoniadi G, Liakopoulos
V, Stefanidis I and Galaktidou G: Inverse association of serum
25-hydroxyvitamin D with markers of inflammation and suppression of
osteoclastic activity in hemodialysis patients. Iran J Kidney Dis.
6:129–135. 2012.PubMed/NCBI
|
|
16
|
Ghaseminejad-Raeini A, Ghaderi A, Sharafi
A, Nematollahi-Sani B, Moossavi M, Derakhshani A and Sarab GA:
Immunomodulatory actions of vitamin D in various immune-related
disorders: A comprehensive review. Front Immunol.
14(950465)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eleftheriadis T, Antoniadi G, Liakopoulos
V, Kartsios C, Stefanidis I and Galaktidou G: Paricalcitol reduces
basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8
production by human peripheral blood mononuclear cells. Int Urol
Nephrol. 42:181–185. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kara AV and Soylu YE: The relationship
between vitamin D and inflammatory markers in maintenance
hemodialysis patients. Int Urol Nephrol. 51:1659–1665.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Iimori S, Mori Y, Akita W, Kuyama T,
Takada S, Asai T, Kuwahara M, Sasaki S and Tsukamoto Y: Diagnostic
usefulness of bone mineral density and biochemical markers of bone
turnover in predicting fracture in CKD stage 5D patients-a
single-center cohort study. Nephrol Dial Transplant. 27:345–351.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Amrein K, Scherkl M, Hoffmann M,
Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, Martucci
G, Pilz S and Malle O: Vitamin D deficiency 2.0: An update on the
current status worldwide. Eur J Clin Nutr. 74:1498–1513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ravani P, Malberti F, Tripepi G, Pecchini
P, Cutrupi S, Pizzini P, Mallamaci F and Zoccali C: Vitamin D
levels and patient outcome in chronic kidney disease. Kidney Int.
75:88–95. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Williams S, Khan L and Licata AA: DXA and
clinical challenges of fracture risk assessment in primary care.
Cleve Clin J Med. 88:615–622. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yucel Kocak S and Ozdemir A: Comparison of
bone mineral density and biochemical factors in hemodialysis and
peritoneal dialysis patients. Clin Nephrol. 98:115–122.
2022.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Yeung WCG, Toussaint ND, Lioufas N, Hawley
CM, Pascoe EM, Elder GJ, Valks A and Badve SV: Vitamin D status and
intermediate vascular and bone outcomes in chronic kidney disease:
A secondary post hoc analysis of IMPROVE-CKD. Intern Med J.
54:1960–1969. 2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Elder GJ and Mackun K: 25-Hydroxyvitamin D
deficiency and diabetes predict reduced BMD in patients with
chronic kidney disease. J Bone Miner Res. 21:1778–1784.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bosworth C, de Boer IH, Targher G,
Kendrick J, Smits G and Chonchol M: The effect of combined calcium
and cholecalciferol supplementation on bone mineral density in
elderly women with moderate chronic kidney disease. Clin Nephrol.
77:358–365. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Mieczkowski M, Żebrowski P, Wojtaszek E,
Stompór T, Przedlacki J, Bartoszewicz Z, Sierdziński J, Wańkowicz
Z, Niemczyk S and Matuszkiewicz-Rowińska J: Long-term
cholecalciferol administration in hemodialysis patients: A
single-center randomized pilot study. Med Sci Monit. 20:2228–2234.
2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tsikliras N, Anagnostara A, Tsantekidou F
and Kyrgialanis A: #495 effect of Vit D supplementation on bone
mineral density in haemodialysis patients. A comparative study.
Nephrol Dial Transplant. 39 (Suppl 1)(gfae069-1604-495)2024.
|
|
29
|
Bhan I, Dobens D, Tamez H, Deferio JJ, Li
YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, et al:
Nutritional vitamin D supplementation in dialysis: A randomized
trial. Clin J Am Soc Nephrol. 10:611–619. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Fernández-Martín JL, Martínez-Camblor P,
Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL,
Rutkowski B, Ferreira A, et al: Improvement of mineral and bone
metabolism markers is associated with better survival in
haemodialysis patients: The COSMOS study. Nephrol Dial Transplant.
30:1542–1551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sasaki K, Shoji T, Kabata D, Shintani A,
Okute Y, Tsuchikura S, Shimomura N, Tsujimoto Y, Nakatani S, Mori
K, et al: Oxidative stress and inflammation as predictors of
mortality and cardiovascular events in hemodialysis patients: The
DREAM cohort. J Atheroscler Thromb. 28:249–260. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Osawa H, Nakamura N, Tsutaya C, Saitoh H,
Shimada M, Murakami R, Fujita T, Narita-Kinjo I, Nagawa D, Nakata
M, et al: Role of high-sensitivity C-reactive protein in future
cardiovascular events in hemodialysis patients. In Vivo.
38:1351–1358. 2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mulkareddy V, Bhalla V, Upadhye S and
Siddam P: The diagnostic dilemma of sarcoidosis: A case of acute
hypercalcemia. Cureus. 12(e10399)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pineault J, Lamarche C, Bell R, Lafrance
JP, Ouellet G, Leblanc M, Pichette V, Bezzaoucha S and Vallée M:
Association of neutrophil-to-lymphocyte ratio with inflammation and
erythropoietin resistance in chronic dialysis patients. Can J
Kidney Health Dis. 4(2054358117735563)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang Y, Liu Y, Lian Y, Li N, Liu H and Li
G: Efficacy of high-dose supplementation with oral vitamin d3 on
depressive symptoms in dialysis patients with vitamin D3
insufficiency: A prospective, randomized, double-blind study. J
Clin Psychopharmacol. 36:229–235. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhao L, Zhu G, Wu L and Xie D: Effects of
vitamin D on inflammatory state in patients with chronic kidney
disease: A controversial issue. Ther Apher Dial. 27:383–393.
2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Eleftheriadis T, Antoniadi G, Liakopoulos
V, Kartsios C and Stefanidis I: Basic science and dialysis:
Disturbances of acquired immunity in hemodialysis patients. Semin
Dial. 20:440–451. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hanna RM, Ghobry L, Wassef O, Rhee CM and
Kalantar-Zadeh K: A practical approach to nutrition, protein-energy
wasting, sarcopenia, and cachexia in patients with chronic kidney
disease. Blood Purif. 49:202–211. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Visiedo L, Pérez Abud R, Rivas-Ruiz F,
Payan JJ, Rey L, Tortajada B and Abilés J: Hypovitaminosis D and
its relationship with nutritional status and quality of life in
patients undergoing haemodialysis. Nutr Hosp. 40:144–150.
2023.PubMed/NCBI View Article : Google Scholar
|
